Atlas Trials

Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)

Clinical trial NCT03416231 · UNKNOWN

Trial details

NCT number
NCT03416231
Sponsor
Affiliated Hospital of North Sichuan Medical College
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
NSCLC
Start date
2016-11-30
Primary completion
2019-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.